Advances in Stem Cell Therapy for Type 2 Diabetes Mellitus
Main Article Content
Abstract
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and impaired insulin secretion, leading to persistent hyperglycemia. Conventional treatments, including lifestyle modifications and pharmacotherapy, often fail to achieve optimal glycemic control and prevent complications. Recent advances in stem cell therapy offer promising avenues for T2DM management. This review discusses the efficacy of mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs) in reducing blood glucose levels, improving Glycated Hemoglobin (HbA1c), and mitigating microvascular and macrovascular complications. Furthermore, we highlight recent innovations in 3D bioprinting and gene therapy that enhance stem cell applications in T2DM.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.